AVR Anteris Technologies Global Corp. - Common Stock
$7,95
Fiyat · May 20, 2026
Temel veriler itibarıyla May 12, 2026
52 Haftlık Aralık
$3–$8
99% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$16
+98% upside
P/E (TTM)
-2.0
ROE
-300.5%
Net Kâr Marjı
-4921.3%
AVR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.95
Piyasa Değeri
$207M
P/E (TTM)
-2.0
EPS (TTM)
$-2.55
Gelir (TTM)
$2M
Temettü Verimi
—
ROE
-300.5%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$3 – $8
AVR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$2M
2024-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.55
2024-12-31
→
2025-12-31
Serbest Nakit Akışı
$-80M
2025-12-31
→
2025-12-31
Marjlar
-4921.3%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
AVR
Akran Ortalaması
P/E (TTM)
-2.0
51.7
P/S (TTM) (F/S (TTM))
108.5
8.5
P/B (F/D)
-2231.0
3.9
Price / FCF (Fiyat / Serbest Nakit Akışı)
-2.6
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
AVR
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-4908.2%
—
Net Profit Margin (Net Kâr Marjı)
-4921.3%
-43.4%
ROA
-181.6%
-23.0%
ROE
-300.5%
-35.4%
ROIC
100961.3%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
AVR
Akran Ortalaması
Current Ratio (Cari Oran)
0.7
3.8
Quick Ratio (Cari Oran)
0.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
AVR
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-29.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
AVR
Akran Ortalaması
AVR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 1 11,1%
- Al 7 77,8%
- Tut 1 11,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-05-14
Medyan
$15.50
Ortalama
$15.75
← Tüm hedeflerin altında
$7.95
Düşük
$15.00
Yüksek
$17.00
Medyan hedef
$15.50
+95,0%
Ortalama hedef
$15.75
+98,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.10%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.28 | $-0.16 | -0.12% |
| 31 Aralık 2025 | $-0.74 | $-0.60 | -0.14% |
| 30 Eylül 2025 | $-0.62 | $-0.58 | -0.04% |
| 30 Haziran 2025 | $-0.58 | $-0.54 | -0.04% |
| 31 Mart 2025 | $-0.61 | $-0.48 | -0.13% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | — |
| BFLY | — | -12.3 | 19.0% | -79.0% | -35.9% | 46.9% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue | $2M | $3M | |
| Cost of Revenue | $569.0K | $1M | |
| R&D Expense | $69M | $51M | |
| SG&A Expense | $26M | $28M | |
| Operating Income | $-94M | $-78M | |
| Other Non-op | $467.0K | $2M | |
| Pretax Income | $-94M | $-76M | |
| Income Tax | $0 | $0 | |
| Net Income | $-94M | $-76M | |
| EPS (Basic) | $-2.55 | $-3.68 | |
| EPS (Diluted) | $-2.55 | $-3.68 | |
| Shares (Basic) | 36,911,472 | 20,252,919 | |
| Shares (Diluted) | 36,911,472 | 20,252,919 | |
| EBITDA | $-92M | · |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $5M | $70M | |
| Receivables | $32.0K | $208.0K | |
| Inventory | $152.0K | $513.0K | |
| Prepaid Expense | $642.0K | $640.0K | |
| Other Current Assets | $2M | $3M | |
| Current Assets | $16M | $75M | |
| PP&E (Net) | $5M | $5M | |
| PP&E (Gross) | $12M | $9M | |
| Accum. Depreciation | $6M | $5M | |
| Intangibles | $65.0K | $189.0K | |
| Other Non-current Assets | · | $0 | |
| Total Assets | $23M | $81M | |
| Accounts Payable | $11M | $6M | |
| Accrued Liabilities | $3M | $4M | |
| Current Liabilities | $21M | $17M | |
| Capital Leases | $2M | $645.0K | |
| Other Non-current Liabilities | $177.0K | $812.0K | |
| Total Liabilities | $23M | $18M | |
| Common Stock | $4.0K | $4.0K | |
| Paid-in Capital | $381M | $350M | |
| Retained Earnings | $-371M | $-276M | |
| AOCI | $-10M | $-11M | |
| Stockholders' Equity | $-93.0K | $63M | |
| Liabilities + Equity | $23M | $81M | |
| Shares Outstanding | 41,579,881 | 35,939,816 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $2M | |
| Stock-based Comp | $8M | $7M | |
| Other Non-cash | $7M | · | |
| Operating Cash Flow | $-78M | $-61M | |
| CapEx | $2M | $2M | |
| Investing Cash Flow | $-596.0K | $-2M | |
| Stock Issued | $26M | $120M | |
| Net Stock Activity | $26M | · | |
| Financing Cash Flow | $21M | $113M | |
| Net Change in Cash | $-58M | $49M | |
| Free Cash Flow | $-80M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -4908.2% | · | |
| Net Margin | -4921.3% | · | |
| Pretax Margin | -4925.5% | · | |
| EBITDA Margin | -4821.4% | · | |
| ROA | -181.6% | · | |
| ROE | -300.5% | · | |
| ROIC | 100961.3% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 0.7 | · | |
| Quick Ratio | 0.0 | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Inventory Turnover | 1.7 | · | |
| Receivables Turnover | 15.9 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -29.2% | · |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $2M | $3M | |
| Net Income TTM | $-94M | $-76M | |
| Market Cap | $207M | · | |
| P/E | -2.0 | -1.5 | |
| P/S | 108.5 | · | |
| P/B | -2231.0 | · | |
| P / Cash Flow | -2.7 | · | |
| P / FCF | -2.6 | · | |
| Earnings Yield | -51.1% | -66.0% |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $494.0K | $310.0K | $429.0K | $618.0K | $556.0K | $536.0K | $769.0K | $632.0K | $766.0K | |
| Cost of Revenue | $114.0K | $91.0K | $123.0K | $148.0K | $207.0K | $209.0K | $443.0K | $312.0K | $473.0K | |
| R&D Expense | $17M | $20M | $17M | $16M | $16M | $13M | $14M | $13M | $12M | |
| SG&A Expense | $7M | $10M | $6M | $5M | $6M | $9M | $7M | $6M | $7M | |
| Operating Income | $-24M | $-29M | $-22M | $-21M | $-22M | $-22M | $-21M | $-18M | $-18M | |
| Other Non-op | $2M | $81.0K | $147.0K | $148.0K | $91.0K | $2M | $123.0K | $100.0K | $414.0K | |
| Pretax Income | $-22M | $-29M | $-22M | $-21M | $-22M | $-19M | $-22M | $-19M | $-16M | |
| Income Tax | $492.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-23M | $-29M | $-22M | $-21M | $-22M | $-19M | $-22M | $-19M | $-16M | |
| EPS (Basic) | $-0.28 | $-0.74 | $-0.62 | $-0.58 | $-0.61 | $-0.72 | $-1.07 | $-0.98 | $-0.91 | |
| EPS (Diluted) | $-0.28 | $-0.74 | $-0.62 | $-0.58 | $-0.61 | $-0.72 | $-1.07 | $-0.98 | $-0.91 | |
| Shares (Basic) | 83,009,832 | -71,225,552 | 36,062,370 | 36,062,364 | 36,012,290 | -37,166,771 | 20,513,631 | 19,015,602 | 17,890,457 | |
| Shares (Diluted) | 83,009,832 | -71,225,552 | 36,062,370 | 36,062,364 | 36,012,290 | -37,166,771 | 20,513,631 | 19,015,602 | 17,890,457 | |
| EBITDA | $-24M | · | $-22M | $-21M | $-21M | · | · | · | · |
Bilanço 25
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | · | · | · | $49M | · | · | · | · | |
| Receivables | $231.0K | $32.0K | $234.0K | $687.0K | $189.0K | $208.0K | · | · | · | |
| Inventory | $122.0K | $152.0K | $436.0K | $449.0K | $364.0K | $513.0K | · | · | · | |
| Prepaid Expense | $2M | $642.0K | $880.0K | $1M | $1M | $640.0K | · | · | · | |
| Other Current Assets | $1M | $2M | $555.0K | $1M | $2M | $3M | · | · | · | |
| Current Assets | $287M | $16M | $11M | $32M | $53M | $75M | · | · | · | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $5M | $5M | · | · | · | |
| PP&E (Gross) | · | $12M | · | · | · | $9M | · | · | · | |
| Accum. Depreciation | · | $6M | · | · | · | $5M | · | · | · | |
| Intangibles | $105.0K | $65.0K | $70.0K | $98.0K | $142.0K | $189.0K | · | · | · | |
| Other Non-current Assets | · | · | $514.0K | $514.0K | · | · | · | · | · | |
| Total Assets | $295M | $23M | $19M | $40M | $59M | $81M | · | · | · | |
| Accounts Payable | $4M | $11M | $4M | $5M | $5M | $6M | · | · | · | |
| Accrued Liabilities | $5M | $3M | $4M | $4M | $6M | $4M | · | · | · | |
| Current Liabilities | $14M | $21M | $13M | $13M | $14M | $17M | · | · | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $535.0K | $645.0K | · | · | · | |
| Other Non-current Liabilities | $193.0K | $177.0K | $653.0K | $767.0K | $689.0K | $812.0K | · | · | · | |
| Total Liabilities | $16M | $23M | $16M | $16M | $16M | $18M | · | · | · | |
| Common Stock | $10.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | · | · | |
| Paid-in Capital | $682M | $381M | $355M | $354M | $352M | $350M | · | · | · | |
| Retained Earnings | $-394M | $-371M | $-341M | $-319M | $-298M | $-276M | · | · | · | |
| AOCI | $-10M | $-10M | $-10M | $-10M | $-11M | $-11M | · | · | · | |
| Stockholders' Equity | $278M | $-93.0K | $4M | $24M | $43M | $63M | · | · | · | |
| Liabilities + Equity | $295M | $23M | $19M | $40M | $59M | $81M | · | · | · | |
| Shares Outstanding | 97,232,054 | 41,579,881 | 36,062,370 | 36,062,370 | 36,062,087 | 35,939,816 | · | · | · |
Nakit Akışı 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $429.0K | $423.0K | $417.0K | $418.0K | $403.0K | $404.0K | $381.0K | $377.0K | $345.0K | |
| Stock-based Comp | $2M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Other Non-cash | $-8M | · | · | · | $-2M | · | · | · | · | |
| Operating Cash Flow | $-29M | $-19M | $-18M | $-20M | $-21M | $-18M | $-14M | $-13M | $-16M | |
| CapEx | $137.0K | $397.0K | $772.0K | $537.0K | $248.0K | $363.0K | $540.0K | $646.0K | $717.0K | |
| Investing Cash Flow | $-182.0K | $-397.0K | $-772.0K | $-537.0K | $1M | $-364.0K | $-553.0K | $-646.0K | $-717.0K | |
| Stock Issued | · | $25M | $0 | $1.0K | $618.0K | $83M | $20M | $16M | $2M | |
| Net Stock Activity | · | · | · | · | $618.0K | · | · | · | · | |
| Financing Cash Flow | $300M | $22M | $-294.0K | $-442.0K | $-1M | $78M | $18M | $14M | $2M | |
| Net Change in Cash | $271M | $3M | $-19M | $-21M | $-22M | $60M | $3M | $267.0K | $-14M | |
| Free Cash Flow | $-29M | · | · | · | $-22M | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4859.7% | · | -5190.0% | -3379.3% | -3917.3% | · | · | · | · | |
| Net Margin | -4660.7% | · | -5185.1% | -3371.2% | -3932.4% | · | · | · | · | |
| Pretax Margin | -4535.6% | · | -5176.9% | -3408.1% | -3944.4% | · | · | · | · | |
| EBITDA Margin | -4772.9% | · | -5190.0% | -3379.3% | -3844.8% | · | · | · | · | |
| ROA | -13.0% | · | -233.2% | -104.5% | -74.4% | · | · | · | · | |
| ROE | -14.3% | · | -1203.0% | -170.7% | -101.1% | · | · | · | · | |
| ROIC | -8.8% | · | -602.1% | -85.6% | -50.3% | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.9 | · | 0.8 | 2.4 | 3.7 | · | · | · | · | |
| Quick Ratio | 2.3 | · | 0.0 | 0.1 | 3.4 | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.5 | · | 0.6 | 0.7 | 1.1 | · | · | · | · | |
| Receivables Turnover | 2.4 | · | 3.7 | 1.8 | 5.9 | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | · | $2M | $3M | $3M | · | · | · | · | |
| Net Income TTM | $-88M | · | $-87M | $-83M | $-79M | · | · | · | · | |
| Market Cap | $540M | · | $162M | $137M | $131M | · | · | · | · | |
| P/E | -2.7 | · | -1.6 | -1.2 | -1.0 | · | · | · | · | |
| P/S | 257.3 | · | 68.4 | 53.1 | 48.2 | · | · | · | · | |
| P/B | 1.9 | · | 43.9 | 5.6 | 3.0 | · | · | · | · | |
| P / Tangible Book | 1.9 | · | 44.7 | 5.6 | 3.0 | · | · | · | · | |
| P / Cash Flow | -18.8 | · | · | · | -6.1 | · | · | · | · | |
| P / FCF | -18.7 | · | · | · | -6.0 | · | · | · | · | |
| Earnings Yield | -37.7% | · | -64.0% | -85.5% | -98.1% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Gelir | $2M | $3M |
| Faaliyet Kâr Marjı % | -4908.2% | — |
| Net Gelir | $-94M | $-76M |
| Seyreltilmiş Hisse Başı Kâr | $-2.55 | $-3.68 |
Bilanço
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Cari Oran | 0.7 | — |
| Cari Oran | 0.0 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Serbest Nakit Akışı | $-80M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.